These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4275983)

  • 41. The effect of probenecid and large dose amphetamine administration on cerebrospinal fluid homovanillic acid.
    Angrist BM; Wilk S; Gershon S
    Biol Psychiatry; 1974 Feb; 8(1):113-4. PubMed ID: 4815338
    [No Abstract]   [Full Text] [Related]  

  • 42. Is cerebrospinal fluid the major avenue for the removal of 5-hydroxyindoleacetic acid from the brain?
    Meek JL; Neff NH
    Neuropharmacology; 1973 May; 12(5):497-9. PubMed ID: 4708479
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of acute and chronic administration of chlomipramine on cerebral serotonin and its metabolism].
    Pons F; Dumas ML; Cadilhac J
    C R Seances Soc Biol Fil; 1973; 167(12):1903-7. PubMed ID: 4802770
    [No Abstract]   [Full Text] [Related]  

  • 44. Digoxin-induced arrest of the cerebrospinal fluid circulation in the infant rat: implications for medical treatment of hydrocephalus during early postnatal life.
    Bass NH; Fällström SP; Lundborg P
    Pediatr Res; 1979 Jan; 13(1):26-30. PubMed ID: 431998
    [No Abstract]   [Full Text] [Related]  

  • 45. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
    Cramer H; Warter JM; Renaud B
    Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of 5-hydroxyindoleacetic acid transport from the spinal fluid by probenecid.
    Zivković B; Bulat M
    J Pharm Pharmacol; 1971 Jul; 23(7):539-40. PubMed ID: 4397456
    [No Abstract]   [Full Text] [Related]  

  • 47. Down's syndrome: a study of sleep patterns related to level of mental retardation.
    Castaldo V
    Am J Ment Defic; 1969 Sep; 74(2):187-90. PubMed ID: 4309776
    [No Abstract]   [Full Text] [Related]  

  • 48. Mechanisms for the elimination of 5-hydroxyindoleacetic acid from brain and cerebrospinal fluid of the rat during postnatal development.
    Atack C; Bass NH; Lundborg P
    Brain Res; 1974 Aug; 77(1):111-20. PubMed ID: 4853133
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of folic acid and vitamin B12 deficiencies on 5-hydroxyindoleacetic acid in human cerebrospinal fluid.
    Botez MI; Young SN; Bachevalier J; Gauthier S
    Ann Neurol; 1982 Nov; 12(5):479-84. PubMed ID: 6185039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Neurological complications in Down's Syndrome].
    Lev N; Melamed E
    Harefuah; 2002 Sep; 141(9):820-3, 857. PubMed ID: 12362489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid.
    van Praag HM; Korf J; Puite J
    Nature; 1970 Mar; 225(5239):1259-60. PubMed ID: 5435360
    [No Abstract]   [Full Text] [Related]  

  • 52. 5-Hydroxy indoleacetic acid (5-HIAA) levels in the cerebrospinal fluid in consciousness and unconsciousness after head injury.
    Vecht CJ; van Woerkom TC; Teelken AW; Minderhoud JM
    Life Sci; 1975 Apr; 16(7):1179-85. PubMed ID: 1134190
    [No Abstract]   [Full Text] [Related]  

  • 53. On the elimination of centrally formed 5-hydroxyindoleacetic acid by cerebrospinal fluid and urine.
    Aizenstein ML; Korf J
    J Neurochem; 1979 Apr; 32(4):1227-33. PubMed ID: 430082
    [No Abstract]   [Full Text] [Related]  

  • 54. Penetration of 5-hydroxyindoleacetic acid across the blood-cerebrospinal fluid barrier.
    Bulat M; Zivković B
    J Pharm Pharmacol; 1973 Feb; 25(2):178-9. PubMed ID: 4146555
    [No Abstract]   [Full Text] [Related]  

  • 55. Tryptophan metabolites in cerebrospinal fluid and urine of patients with affective disorders.
    Nair MC; Rao BS
    Indian J Med Res; 1982 Feb; 75():274-6. PubMed ID: 6177630
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of probenecid on the elimination from CSF of intraventricularly injected 5-hydroxyindolecetic acid in normal and hydrocephalic dogs.
    Anderson H; Roos BE
    J Pharm Pharmacol; 1968 Nov; 20(11):879-81. PubMed ID: 4387498
    [No Abstract]   [Full Text] [Related]  

  • 57. Production and removal of 5-hydroxyindole acetic acid in the spinal region of the rabbit.
    Davidson DL; Glen AI
    Exp Neurol; 1977 Feb; 54(2):291-302. PubMed ID: 838019
    [No Abstract]   [Full Text] [Related]  

  • 58. [Free amino-acids levels of cerebrospinal fluid in baby infants with Down's syndrome (author's transl)].
    Priscu R; Moraru I; Albu A; Sichitiu S
    Humangenetik; 1974 Jan; 21(1):63-8. PubMed ID: 4276064
    [No Abstract]   [Full Text] [Related]  

  • 59. Early developmental staging as a prophecy index in Down's syndrome.
    Gibson D
    Am J Ment Defic; 1966 May; 70(6):825-8. PubMed ID: 4223000
    [No Abstract]   [Full Text] [Related]  

  • 60. Selected ion monitoring assay for biogenic amine metabolites and probenecid in human lumbar cerebrospinal fluid.
    Faull KF; Anderson PJ; Barchas JD; Berger PA
    J Chromatogr; 1979 Aug; 163(4):337-49. PubMed ID: 544601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.